Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 18 minutes agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Injectables Trends From Around the World
Allure via Yahoo News· 4 days agoUntil then, companies in the United States are working on making their own skin boosters. For example, Juvéderm’s skin booster, Skinvive, was granted < ...
New 'FLiRT' COVID-19 Variants Are Responsible For 25% Of Infections
Women's Health via Yahoo News· 5 days agoStaying up to date with your booster shots can provide some protection against this new variant,...
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise
MedPage Today· 4 days agoNews, features, and commentary about cancer-related issues
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 hours agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
New mRNA cancer vaccine helps immune system fight deadly brain tumors
MedicalNewsToday via AOL· 6 days agoResearchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the...
'Low' risk and tests for all? Botched COVID response hangs over feds' bird-flu plans
Just the News· 6 days agoA shadowy virus is spreading with unknown frequency and risk to humans. The Centers for Disease...
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Colorado Springs Gazette· 6 days agoFirst quarter 2024 total revenue of $29.5 million, which includes TAVALISSE® net product sales of $21.1 million and REZLIDHIA® net product sales of $4.9 millionExpanded Rigel's portfolio with acquisition of